Dr. Irene Rombel is the CEO, President and Co-Founder of BioCurie, a TechBio company that is harnessing AI to transform the development and manufacturing of genomic medicines. Irene is an industry veteran with 25+ years of leadership experience in science and business, spanning academia, investing, and biopharma, including leadership roles at Spark Therapeutics and J&J.